A loophole left open for defendants in a critical class action ruling by the U.S. Supreme Court last year is making little headway in the courts, with the U.S. Court of Appeals for the Seventh Circuit striking down the procedural maneuver this week.
Monday's landmark decision by the U.S. Supreme Court in "Bristol-Myers Squibb v. Superior Court of California" has already had a massive impact. In mere hours, a judge in Missouri granted a motion for mistrial in a pivotal trial over Johnson & Johnson's baby powder due to the court's decision. Even
The ACLU's legal efforts in obtaining records of everyone detained or removed under President Donald Trump's executive orders on immigration might have to wait a bit longer after the U.S. Department of Justice moved last month to coordinate the organization's 13 lawsuits into multidistrict litigatio
Eli Lilly & Co. plans to move this month to dismiss a long-standing appeal in a case brought on behalf of a proposed class of consumers who used Cymbalta, an antidepressant prescription drug, according to a status report filed this week. The reason: Monday's decision by the U.S. Supreme Court in "Mi
In a ruling reverberating through the class action bar, the U.S. Supreme Court has blocked a controversial procedural tool that allowed plaintiffs attorneys to appeal class certification orders by dismissing their own case.
Pointing to a rise in the use of outside financiers in lawsuits, the U.S. Chamber of Commerce is petitioning the federal judiciary to adopt a nationwide disclosure requirement for third-party litigation funding.
Plaintiffs attorneys suing over the Sanofi breast cancer drug Taxotere say the company's lawyers should be penalized for making an "unseemly attempt" to reveal funding arrangements.
It's time to give judges clear rules for managing MDLs, says John Rabiej, director of Duke Law School's Center for Judicial Studies. For starters, he'd spread the biggest cases across more judges.
Five plaintiffs who saw a $502 million jury verdict cut to $150 million last year say the state law unconstitutionally discriminates against the old and the poor.
In five trials over the safety of its talcum powder, Johnson & Johnson has racked up four losses. Thursday's verdict from a Missouri jury was the biggest blow so far.